In this episode, I sat down with Patrick Leung, CTO at Faro Health, to talk about how they're using AI to tackle huge inefficiencies in clinical trial design. Patrick shared insights from his career—including key roles at Google and Two Sigma—and why he chose to join Faro to help streamline how new drugs get to market.

We discussed:
- Why traditional clinical trials are becoming increasingly slow and costly.
- How Faro’s AI-based approach drastically shortens trial planning from months to hours.
- The real-world impact of Faro’s work with leading pharma companies, including Merck and Recursion.
- Patrick’s perspective on balancing tech innovation with human expertise in healthcare.

Link to the study mentioned: https://link.springer.com/article/10.1007/s43441-024-00666-x

Guest Info:
Patrick Leung, CTO at Faro Health  
Website: https://farohealth.com/  
LinkedIn: https://www.linkedin.com/in/puiwah/  

Connect with me on LinkedIn: https://www.linkedin.com/in/gregtoroosian/